FutureMeds appoints Dr Radoslaw Janiak as CEO.
Updated: May 5, 2020
FutureMeds, a UK based Dedicated Research Sites Network announces the appointment of Dr Radoslaw Janiak as its Chief Executive Officer.
With its operations in UK, Poland and Ukraine, FutureMeds has aggressive expansion plans to build Dedicated Research Sites in key geographical locations across Europe.
Dr Janiak graduated from Medical University, Warsaw and began his career as a medical doctor at Praski Hospital, Warsaw. He opened one of the first Dedicated Research Sites in Poland which was subsequently acquired by Synexus - one of their first steps in expanding outside the UK. On joining Synexus, Dr Janiak became responsible for operations in Poland, Ukraine, Hungary, Bulgaria and Romania, before being appointed as COO. After acquisition by PPD, Dr Janiak took on the position of President and Chief Operating Officer, leading Synexus in Europe, USA, Africa and Asia.
Dr Janiak commented on his appointment: “I am extremely happy to be joining FutureMeds and lead the expansion of this exciting new organisation. I have full confidence that in this current challenging period, when speed is of the essence, independent Site Networks like FutureMeds will contribute significantly to Medical Research. Our current Sites in Poland are ready now with a flexible model to execute trials with Telemedicine Solutions. And we continue to plan and execute the expansion of our footprint in Europe.”